Anti-Spike Antibody
Anti-SARS-CoV-2 Antibody IgG Quantitative and Titer Detection Kit (Spike RBD) |
|||
RAS-T093 | ACROBIOSYSTEMS | 96tests | EUR 845.3 |
Description: The newly identified Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has posed a serious threat to human health. A rapid and effective Assay kit detecting the levels of anti-SARS-CoV-2 in human serum can facilitate research on characterization of antibodies produced in response to SARS-CoV-2 infection. |
Human IgG antibody Laboratories manufactures the anti-spike antibody reagents distributed by Genprice. The Anti-Spike Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike Antibody. Other Anti-Spike products are available in stock. Specificity: Anti-Spike Category: Antibody
Anti-Spike-RBD-fully-human-mAb(IgG) |
||
EnoGene | Human,-Human-IgG1.Affinity:(mol)6.99*10-10(Fortebio),0.38-nM(ELISA).-FACs-Blocking:-0.803-nM- | EUR 416.5 |
Description: Human, Human IgG1.Affinity: (mol) 6.99*10-10 (Fortebio) , 0.38 nM (ELISA) . FACs Blocking: 0.803 nM |
Anti-Spike-RBD-fully-human-mAb(IgG) |
||
EnoGene | Human,-Human-IgG1.-Affinity:(mol)3.1*10-10(Fortebio)0.3-nM(ELISA).-FACs-Blocking:-0.889-nM. | EUR 416.5 |
Description: Human, Human IgG1. Affinity: (mol) 3.1*10-10 (Fortebio) 0.3 nM (ELISA) . FACs Blocking: 0.889 nM. |
Anti-Spike-RBD-fully-human-mAb(IgG) |
||
EnoGene | Humanized-Monoclonal-Antibody,-human-IgG1.-Affinity:0.561-nM(By-ELISA) | EUR 416.5 |
Description: Humanized Monoclonal Antibody, human IgG1. Affinity:0.561 nM (By ELISA) |
Anti-Spike-RBD-fully-human-mAb(IgG) |
||
EnoGene | Humanized-Monoclonal-Antibody.-human-IgG1.-Affinity:0.762-nM(By-ELISA) | EUR 416.5 |
Description: Humanized Monoclonal Antibody. human IgG1. Affinity:0.762 nM (By ELISA) |
Rabbit IgG Anti HCoV-229E Spike (S1) Polyclonal Antibody |
||
The Native Antigen Company | 0.1 | EUR 405.69 |
Description: Polyclonal antibody against human coronavirus 229E. |
Rabbit IgG Anti HCoV-229E Spike (S1) Polyclonal Antibody |
||
The Native Antigen Company | 0.5 | EUR 1259.17 |
Description: Polyclonal antibody against human coronavirus 229E. |
Rabbit IgG Anti HCoV-OC43 Spike (S1) Polyclonal Antibody |
||
The Native Antigen Company | 0.1 | EUR 405.69 |
Description: Polyclonal antibody against human coronavirus OC43. |
Mouse Anti Porcine Coronavirus Spike Antibody (1E11) |
|||
MAB12432-100 | The Native Antigen Company | 0.1 | EUR 276.84 |
Description: Mouse monoclonal antibody specific for the spike (S) protein of the swine enteropathogenic coronavirus, Transmissible Gastroenteritis Virus (TGEV). |
Mouse Anti Porcine Coronavirus Spike Antibody (1E11) |
|||
MAB12432-500 | The Native Antigen Company | 0.5 | EUR 692.74 |
Description: Mouse monoclonal antibody specific for the spike (S) protein of the swine enteropathogenic coronavirus, Transmissible Gastroenteritis Virus (TGEV). |
Mouse Anti MERS Coronavirus Spike (S1) Antibody (3871) |
|||
MAB12395-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
Description: Mouse monoclonal antibody specific for MERS-CoV Spike S1 |
Mouse Anti MERS Coronavirus Spike (S1) Antibody (3871) |
|||
MAB12395-500 | The Native Antigen Company | 0.5 | EUR 691.46 |
Description: Mouse monoclonal antibody specific for MERS-CoV Spike S1 |
Mouse Anti MERS Coronavirus Spike (S1) Antibody (3872) |
|||
MAB12396-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
Description: Mouse monoclonal antibody specific for MERS-CoV Spike S1 |
Mouse Anti MERS Coronavirus Spike (S1) Antibody (3872) |
|||
MAB12396-500 | The Native Antigen Company | 0.5 | EUR 691.46 |
Description: Mouse monoclonal antibody specific for MERS-CoV Spike S1 |
Mouse Anti MERS Coronavirus Spike (S1) Antibody (3873) |
|||
MAB12397-100 | The Native Antigen Company | 0.1 | EUR 275.56 |
Description: Mouse monoclonal antibody specific for MERS-CoV Spike S1 |
Mouse Anti MERS Coronavirus Spike (S1) Antibody (3873) |
|||
MAB12397-500 | The Native Antigen Company | 0.5 | EUR 691.46 |
Description: Mouse monoclonal antibody specific for MERS-CoV Spike S1 |
SARS-CoV Spike Antibody |
|||
3219-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|||
3219-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|||
3221-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|||
3221-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: SARS-CoV Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|||
3223-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|||
3223-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: SARS Spike Antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|||
3225-002mg | ProSci | 0.02 mg | EUR 206.18 |
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|||
3225-01mg | ProSci | 0.1 mg | EUR 523.7 |
Description: SARS-CoV Spike antibody: A novel coronavirus has recently been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Coronaviruses are a major cause of upper respiratory diseases in humans. The genomes of these viruses are positive-stranded RNA approximately 27-31kb in length. SARS infection can be mediated by the binding of the viral spike protein, a glycosylated 139 kDa protein and the major surface antigen of the virus, to the angiotensin-converting enzyme 2 (ACE2) on target cells. This binding can be blocked by a soluble form of ACE2. |
SARS-CoV Spike Antibody |
|||
21807 | SAB | 100ul | EUR 1039 |